bodily fluid kit
Search documents
Acme United’s Record 2025 Strengthens Long-Term Outlook; Buy Rating Reaffirmed
Smallcaps Investment Research· 2026-03-21 11:12
In 2025, Acme United Corporation (US: ACU – $43.41) delivered record sales and earnings, achieving the strongest financial performance in its history despite a year marked by volatility and uncertainty. The Company navigated tariff disruptions, shifting customer demand, and global supply chain challenges to produce improved results across most of its key metrics. Several initiatives strengthened the Company’s long-term competitive position in 2025. The first aid division introduced the RFID SmartCompliance ...